Instead, we focused on determining whether intracellular PD-L1 in ovarian cancer cells/tumors can promote tumor progression and whether targeting intracellular PD-L1 would induce ovarian cancer-cell growth inhibition and apoptosis. Here, CD274 is linked to ovarian carcinoma.